The effect of pleiotrophin signaling on adipogenesis

FEBS Letters

Volumn 581, Issue 3, 2007, Pages 382-388

  Gu, Dayong ^a   Yu, Bing ^a   Zhao, Chen ^b   Ye, Wenbin ^a   Lv, Qing ^a   Hua, Zhong ^a   Ma, Jiangan ^b   Zhang, Yaou ^a  

^a TSINGHUA UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Catenin; 3T3 L1 preadipocyte; Adipogenesis; Glycogen synthase kinase 3 ; Pleiotrophin

Indexed keywords

BETA CATENIN; DEXAMETHASONE; GLYCOGEN SYNTHASE KINASE 3BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLEIOTROPHIN; SMALL INTERFERING RNA; WNT PROTEIN;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN 3T3; CONTROLLED STUDY; GENE EXPRESSION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPECTROPHOTOMETRY; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; BASE SEQUENCE; BETA CATENIN; CARRIER PROTEINS; CELL DIFFERENTIATION; CYTOKINES; DEXAMETHASONE; DOWN-REGULATION; GENE EXPRESSION PROFILING; MICE; MODELS, BIOLOGICAL; PPAR GAMMA; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 33846467576     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.12.043     Document Type: Article

References (41)

1. Deuel T.F., Zhang N., Yeh H.J., Silos-Santiago I., and Wang Z.Y. Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. Arch. Biochem. Biophys. 397 (2002) 162-171
2. Pufe T., Bartscher M., Petersen W., Tillmann B., and Mentlein R. Pleiotrophin, an embryonic differentiation and growth factor, is expressed in osteoarthritis. Osteoarthritis Cartilage. 11 (2003) 260-264
3. Kadomatsu K., and Muramatsu T. Midkine and pleiotrophin in neural development and cancer. Cancer Lett. 204 (2004) 127-143
4. Blondet B., Carpentier G., Lafdil F., and Courty J. Pleiotrophin cellular localization in nerve regeneration after peripheral nerve injury. J. Histochem. Cytochem. 53 (2005) 971-977
5. Kinnunen A., Niemi M., Kinnunen T., Kaksonen M., Nolo R., and Rauvala H. Heparan sulphate and HB-GAM (heparin-binding growth-associated molecule) in the development of the thalamocortical pathway of rat brain. Eur. J. Neurosci. 11 (1999) 491-502
6. Azizan A., Gaw J.U., Govindraj P., Tapp H., and Neame P.J. Chondromodulin I and pleiotrophin gene expression in bovine cartilage and epiphysis. Matrix Biol. 19 (2000) 521-531
7. Hienola A., Pekkanen M., Raulo E., Vanttola P., and Rauvala H. HB-GAM inhibits proliferation and enhances differentiation of neural stem cells. Mol. Cell Neurosci. 26 (2004) 75-88
8. Vanderwinden J.M., Mailleux P., Schiffmann S.N., and Vanderhaeghen J.J. Cellular distribution of the new growth factor pleiotrophin (HB-GAM) mRNA in developing and adult rat tissues. Anat. Embryol (Berl). 186 (1992) 387-406
9. Brigstock D.R., Kim G.Y., and Steffen C.L. Pig uterine luminal fluid contains the developmentally regulated neurotrophic factor, pleiotrophin. J. Endocrinol. 148 (1996) 103-111
10. Silos-Santiago I., Yeh H.J., Gurrieri M.A., Guillerman R.P., Li Y.S., Wolf J., Snider W., and Deuel T.F. Localization of pleiotrophin and its mRNA in subpopulations of neurons and their corresponding axonal tracts suggests important roles in neural-glial interactions during development and in maturity. J. Neurobiol. 31 (1996) 283-296
11. Chung H.W., Wen Y., Choi E.A., Hao-Li, Moon H.S., Yu H.K., and Polan M.L. Pleiotrophin (PTN) and midkine (MK) mRNA expression in eutopic and ectopic endometrium in advanced stage endometriosis. Mol. Hum. Reprod. 8 (2002) 350-355
12. Yeh H.J., He Y.Y., Xu J., Hsu C.Y., and Deuel T.F. Upregulation of pleiotrophin gene expression in developing microvasculature, macrophages, and astrocytes after acute ischemic brain injury. J. Neurosci. 18 (1998) 3699-3707
13. Antoine M., Tag C.G., Wirz W., Borkham-Kamphorst E., Sawitza I., Gressner A.M., and Kiefer P. Upregulation of pleiotrophin expression in rat hepatic stellate cells by PDGF and hypoxia: implications for its role in experimental biliary liver fibrogenesis. Biochem. Biophys. Res. Commun. 337 (2005) 1153-1164
14. Vacherot F., Laaroubi K., Caruelle D., Delbe J., Barritault D., Caruelle J.P., and Courty J. Upregulation of heparin-affin regulatory peptide by androgen. In Vitro Cell Dev. Biol. Anim. 31 (1995) 647-648
15. Laaroubi K., Vacherot F., Delbe J., Caruelle D., Barritault D., and Courty J. Biochemical and mitogenic properties of the heparin-binding growth factor HARP. Prog. Growth Factor Res. 6 (1995) 25-34
16. Souttou B., Ahmad S., Riegel A.T., and Wellstein A. Signal transduction pathways involved in the mitogenic activity of pleiotrophin. Implication of mitogen-activated protein kinase and phosphoinositide 3-kinase pathways. J. Biol. Chem. 272 (1997) 19588-19593
17. Souttou B., Juhl H., Hackenbruck J., Rockseisen M., Klomp H.J., Raulais D., Vigny M., and Wellstein A. Relationship between serum concentrations of the growth factor pleiotrophin and pleiotrophin-positive tumors. J. Natl. Cancer Inst. 90 (1998) 468-1473
18. Klomp H.J., Zernial O., Flachmann S., Wellstein A., and Juhl H. Significance of the expression of the growth factor pleiotrophin in pancreatic cancer patients. Clin. Cancer Res. 8 (2002) 823-827
19. Hatziapostolou M., Delbe J., Katsoris P., Polytarchou C., Courty J., and Papadimitriou E. Heparin affin regulatory peptide is a key player in prostate cancer cell growth and angiogenicity. Prostate 65 (2005) 151-158
20. Wu H., Barusevicius A., Babb J., Klein-Szanto A., Godwin A., Elenitsas R., Gelfand J.M., Lessin S., and Seykora J.T. Pleiotrophin expression correlates with melanocytic tumor progression and metastatic potential. J. Cutan. Pathol. 32 (2005) 125-130
21. Li G., Hu Y., Huo Y., Liu M., Freeman D., Gao J., Liu X., Wu D.C., and Wu H. PTEN deletion leads to up-regulation of a secreted growth factor pleiotrophin. J. Biol. Chem. 281 (2006) 10663-10668
22. Sakurai H., Bush K.T., and Nigam S.K. Identification of pleiotrophin as a mesenchymal factor involved in ureteric bud branching morphogenesis. Development. 128 (2001) 3283-3293
23. Hirai S., Yamanaka M., Kawachi H., Matsui T., and Yano H. Activin A inhibits differentiation of 3T3-L1 preadipocyte. Mol. Cell Endocrinol. 232 (2005) 21-26
24. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., and Tuschl T. Duplexes of 21-nucleotide RNAs mediate interference in cultured mammalian cells. Nature 411 (2001) 494-498
25. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W.S., and Khvorova A. Rational siRNA design for RNA interference. Nat. Biotechnol. 22 (2004) 326-330
26. Bennett C.N., Ross S.E., Longo K.A., Bajnok L., Hemati N., Johnson K.W., Harrison S.D., and MacDougald O.A. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277 (2002) 30998-31004
27. Meng K., Rodriguez-Pena A., Dimitrov T., Chen W., Yamin M., Noda M., and Deuel T.F. Pleiotrophin signals increased tyrosine phosphorylation of beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc. Natl. Acad. Sci. USA 97 (2000) 2603-2608
28. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., and MacDougald O.A. Inhibition of adipogenesis by Wnt signaling. Science 289 (2000) 950-953
29. Liu J., and Farmer S.R. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes. J. Biol. Chem. 279 (2004) 45020-45027
30. Steppan C.M., and Lazar M.A. Resistin and obesity-associated insulin resistance. Trends Endocrinol. Metab. 13 (2002) 18-23
31. Giorgino F., Laviola L., and Eriksson J.W. Regional differences of insulin action in adipose tissue: insights from in vivo and in vitro studies. Acta Physiol. Scand. 183 (2005) 13-30
32. MacDougald O.A., and Mandrup S. Adipogenesis: forces that tip the scales. Trends Endocrinol. Metab. 13 (2002) 5-11
33. Pariser H., Perez-Pinera P., Ezquerra L., Herradon G., and Deuel T.F. Pleiotrophin stimulates tyrosine phosphorylation of beta-adducin through inactivation of the transmembrane receptor protein tyrosine phosphatase beta/zeta. Biochem. Biophys. Res. Commun. 335 (2005) 232-239
34. Kennell J.A., and MacDougald O.A. Wnt signaling inhibits adipogenesis through beta-catenin-dependent and -independent mechanisms. J. Biol. Chem. 280 (2005) 24004-24010
35. Bhanot P., Brink M., Samos C.H., Hsieh J.C., Wang Y., Macke J.P., Andrew D., Nathans J., and Nusse R. A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 382 (1996) 225-230
36. Bejsovec A. Wnt signaling: an embarrassment of receptors. Curr. Biol. 10 (2000) R919-R922
37. Persad S., Troussard A.A., McPhee T.R., Mulholland D.J., and Dedhar S. Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J. Cell. Biol. 153 (2001) 1161-1174
38. Kennell J.A., O'Leary E.E., Gummow B.M., Hammer G.D., and MacDougald O.A. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors. Mol. Cell Biol. 23 (2003) 5366-5375
39. Souttou B., Raulais D., and Vigny M. Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways. J. Cell Physiol. 187 (2001) 59-64
40. Bowden E.T., Stoica G.E., and Wellstein A. Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase. J. Biol. Chem. 277 (2002) 35862-35868
41. Powers C., Aigner A., Stoica G.E., McDonnell K., and Wellstein A. Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth. J. Biol. Chem. 277 (2002) 14153-14158